HCFA Commits To Coverage Decision On Prosorba For Rheumatoid Arthritis
This article was originally published in The Gray Sheet
Executive Summary
Cypress Bioscience will submit data used to obtain FDA approval of the Prosorba column for rheumatoid arthritis (RA) in an upcoming review for national Medicare coverage by the Health Care Financing Administration, the company reported Feb 22.